Advanced search

Drug policy for visceral leishmaniasis: a cost-effectiveness analysis

Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
VANLERBERGHE, V, G DIAP, PJ GUERIN, F MEHEUS, S GERSTL, Patrick Van Der Stuyft, and M BOELAERT. 2007. “Drug Policy for Visceral Leishmaniasis: a Cost-effectiveness Analysis.” Tropical Medicine & International Health 12 (2): 274–283.
APA
VANLERBERGHE, V, DIAP, G., GUERIN, P., MEHEUS, F., GERSTL, S., Van Der Stuyft, P., & BOELAERT, M. (2007). Drug policy for visceral leishmaniasis: a cost-effectiveness analysis. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 12(2), 274–283.
Vancouver
1.
VANLERBERGHE V, DIAP G, GUERIN P, MEHEUS F, GERSTL S, Van Der Stuyft P, et al. Drug policy for visceral leishmaniasis: a cost-effectiveness analysis. TROPICAL MEDICINE & INTERNATIONAL HEALTH. BLACKWELL PUBLISHING; 2007;12(2):274–83.
MLA
VANLERBERGHE, V, G DIAP, PJ GUERIN, et al. “Drug Policy for Visceral Leishmaniasis: a Cost-effectiveness Analysis.” TROPICAL MEDICINE & INTERNATIONAL HEALTH 12.2 (2007): 274–283. Print.
@article{385783,
  author       = {VANLERBERGHE, V and DIAP, G and GUERIN, PJ and MEHEUS, F and GERSTL, S and Van Der Stuyft, Patrick and BOELAERT, M},
  issn         = {1360-2276},
  journal      = {TROPICAL MEDICINE & INTERNATIONAL HEALTH},
  language     = {eng},
  number       = {2},
  pages        = {274--283},
  publisher    = {BLACKWELL PUBLISHING},
  title        = {Drug policy for visceral leishmaniasis: a cost-effectiveness analysis},
  volume       = {12},
  year         = {2007},
}

Web of Science
Times cited: